Skip to content

United Therapeutics UTHR Debt Repayments

Debt Repayments at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$33M+3.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$439.25M
Merck & Co. logo
Merck & Co.MRK
$1.14B-54.4%
LQD
Liquidia CorporationLQDA
$19.97M+841%
Amgen logo
AmgenAMGN
$833M-66.7%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$4.06M+100%

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$26.25B+90.4%
P/E20.4×+9.3×
P/S8.3×+3.8×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLinesOfCredit.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's debt repayments?
United Therapeutics (UTHR) reported debt repayments of $0 in Q1 2026.
How has United Therapeutics's debt repayments changed year-over-year?
United Therapeutics's debt repayments decreased by 100.0% year-over-year, from $100M to $0.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.